10/30
10:47 am
ipha
Innate Pharma (NASDAQ:IPHA) was upgraded by analysts at HC Wainwright from a "hold" rating to a "strong-buy" rating.
Low
Report
Innate Pharma (NASDAQ:IPHA) was upgraded by analysts at HC Wainwright from a "hold" rating to a "strong-buy" rating.
10/29
08:08 am
ipha
Innate Pharma (NASDAQ:IPHA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock.
Report
Innate Pharma (NASDAQ:IPHA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock.
10/29
06:09 am
ipha
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
Low
Report
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
10/29
06:09 am
ipha
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
Low
Report
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
10/29
05:27 am
ipha
Rating for IPHA
Low
Report
Rating for IPHA
9/18
08:09 am
ipha
Innate Pharma (NASDAQ:IPHA) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Innate Pharma (NASDAQ:IPHA) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
9/18
08:09 am
ipha
Innate Pharma (NASDAQ:IPHA) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $2.00 price target on the stock, down previously from $10.00.
Low
Report
Innate Pharma (NASDAQ:IPHA) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $2.00 price target on the stock, down previously from $10.00.
9/18
07:09 am
ipha
Rating for IPHA
Low
Report
Rating for IPHA
9/18
06:04 am
ipha
Innate Pharma downgraded to Neutral from Buy at H.C. Wainwright
Medium
Report
Innate Pharma downgraded to Neutral from Buy at H.C. Wainwright
9/18
06:04 am
ipha
Innate Pharma downgraded to Neutral from Buy at H.C. Wainwright
Medium
Report
Innate Pharma downgraded to Neutral from Buy at H.C. Wainwright
9/17
06:35 pm
ipha
Innate Pharma downgraded to Market Perform from Outperform at Leerink
Low
Report
Innate Pharma downgraded to Market Perform from Outperform at Leerink